학술논문

Prevalence and correlates of obstructive lung disease among people who inject drugs, San Diego, California
Document Type
article
Source
Subject
Biomedical and Clinical Sciences
Public Health
Health Sciences
Clinical Sciences
Lung
Infectious Diseases
Emerging Infectious Diseases
Clinical Research
Digestive Diseases
Hepatitis - C
Substance Misuse
HIV/AIDS
Prevention
Hepatitis
Liver Disease
Respiratory
Good Health and Well Being
Adult
California
Cohort Studies
Cross-Sectional Studies
Female
HIV Infections
Hepacivirus
Hepatitis C
Humans
Logistic Models
Lung Diseases
Obstructive
Male
Middle Aged
Pharmaceutical Preparations
Prevalence
Risk Factors
Substance Abuse
Intravenous
Tuberculosis
Obstructive lung disease
Smoking
Mycobacterium tuberculosis infection
Injection drug use
Medical and Health Sciences
Psychology and Cognitive Sciences
Substance Abuse
Biochemistry and cell biology
Pharmacology and pharmaceutical sciences
Epidemiology
Language
Abstract
BackgroundPulmonary tissue damage leading to obstructive lung disease (OLD) could result from intravenous administration of insoluble particles found in illicit drugs. This study described the prevalence and identified correlates of OLD among people who inject drugs (PWID).MethodsIn 2012-2016, a community-based cohort of PWID who had injected within the past month were enrolled in a study to assess HIV, hepatitis C virus (HCV) andMycobacterium tuberculosis (Mtb) infections and their related risk factors. Data were obtained through face-to-face interviews, serological testing and spirometry. Baseline data were used for a cross-sectional analysis of the prevalence and correlates of OLD, defined as FEV1/FVC < 0.7. Univariate and multivariable logistic regression were used to identify factors associated with OLD.ResultsAmong 516 participants who had complete spirometry and interview results, the mean age was 43.3 years, 73.6 % were male, 9.5 % were Black, 91.1 % smoked cigarettes and 18.2 % had OLD. Few (9.6 %) PWID with OLD reported a previous diagnosis of COPD although many (44.7 %) reported related symptoms. Black race (AOR = 2.66, 95 %CI: 1.37, 5.17), pack-years smoked (AOR = 1.06/5 years, 95 %CI: 1.01, 1.12), and duration of injection drug use (AOR = 1.13, 95 %CI: 1.01, 1.27) were independently associated with OLD after controlling for age.ConclusionsThe prevalence of OLD was high in this cohort and associated with Black race and cigarette smoking-known risk factors. In addition, OLD prevalence increased with greater duration of injection drug use, suggesting a link between cumulative exposure to injected insoluble particles and OLD. Further examination of these adulterants and lung pathology are needed.